(Q33993685)

30 July 2017

1 reference

title

A rational approach to drug therapy of type 2 diabetes mellitus (English)

1 reference

30 July 2017

1 reference

Chehade JM

1

1 reference

PubMed ID

10929931

30 July 2017

Mooradian AD

series ordinal

2

1 reference

30 July 2017

1 July 2000

1 reference

30 July 2017

1 reference

30 July 2017

60

1 reference

30 July 2017

1

1 reference

30 July 2017

95-113

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200060010-00006

30 July 2017

0 references

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200060010-00006

Metabolic effects of troglitazone monotherapy in type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00003495-200060010-00006

Significance of testing platelet functions in vitro

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00003495-200060010-00006

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00003495-200060010-00006

21 January 2018

1 reference

12 December 2020

Insulin and Cardiovascular Disease: Paris Prospective Study

1 reference

12 December 2020

Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.

1 reference

12 December 2020

Improvement of HbA1c and blood glucose stability in IDDM patients treated with lispro insulin analog in external pumps.

1 reference

12 December 2020

1 reference

12 December 2020

Do non-insulin-dependent diabetes mellitus and cardiovascular disease share common antecedents?

1 reference

12 December 2020

Cardiovascular events and correlates in the Veterans Affairs Diabetes Feasibility Trial. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes

1 reference

12 December 2020

Insulin lispro in CSII: results of a double-blind crossover study

1 reference

12 December 2020

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study

1 reference

12 December 2020

Hepatic dysfunction associated with troglitazone

1 reference

12 December 2020

Effect of troglitazone in insulin-treated patients with type II diabetes mellitus. Troglitazone and Exogenous Insulin Study Group.

1 reference

12 December 2020

Lipoprotein patterns in diet, sulphonylurea, and insulin treated diabetics.

1 reference

12 December 2020

The University Group Diabetes Program. A statistician looks at the mortality results

1 reference

12 December 2020

American diabetes association policy statement: the UGDP controversy

1 reference

12 December 2020

1 reference

12 December 2020

Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15-year follow-up

1 reference

12 December 2020

Thiazolidinediones in the treatment of insulin resistance and type II diabetes

1 reference

12 December 2020

Effects of therapy on plasma-high-density-lipoprotein-cholesterol concentration in diabetes mellitus

1 reference

12 December 2020

Characteristics of non-insulin-dependent diabetic patients with secondary failure to oral antidiabetic therapy.

1 reference

12 December 2020

Plasma insulin as coronary heart disease risk factor: relationship to other risk factors and predictive value during 9 1/2-year follow-up of the Helsinki Policemen Study population.

1 reference

12 December 2020

A novel antidiabetic drug, troglitazone--reason for hope and concern

1 reference

12 December 2020

Seminars in Medicine of the Beth Israel Hospital, Boston. Non-insulin-dependent diabetes mellitus - a genetically programmed failure of the beta cell to compensate for insulin resistance

1 reference

12 December 2020

Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994.

1 reference

12 December 2020

American Diabetes Association Scientific Sessions, 1995: Non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Pathophysiology of type 2 diabetes and modes of action of therapeutic interventions

1 reference

12 December 2020

Effect of insulin therapy on macrovascular risk factors in type 2 diabetes

1 reference

12 December 2020

Long-term effects of modest weight loss in type II diabetic patients

1 reference

12 December 2020

Effects of amylin and the amylin agonist pramlintide on glucose metabolism

1 reference

12 December 2020

Relationship of body fat distribution to blood pressure, carbohydrate tolerance, and plasma lipids in healthy obese women

1 reference

12 December 2020

Chronic treatment of African-American type 2 diabetic patients with alpha-glucosidase inhibition

1 reference

12 December 2020

Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Inf

1 reference

12 December 2020

The efficacy and safety of miglitol therapy compared with glibenclamide in patients with NIDDM inadequately controlled by diet alone

1 reference

12 December 2020

Effect of obesity on the response to insulin therapy in noninsulin-dependent diabetes mellitus

1 reference

12 December 2020

Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus. A randomized, controlled trial

1 reference

12 December 2020

Acarbose. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential

1 reference

12 December 2020

Factors influencing the absorption, serum insulin concentration, and blood glucose responses after injections of regular insulin and various insulin mixtures.

1 reference

12 December 2020

Dietary therapy in diabetes mellitus. Is there a single best diet?

1 reference

12 December 2020

Coronary Heart Disease Incidence and Cardiovascular Mortality in Busselton with Reference to Glucose and Insulin Concentrations

1 reference

12 December 2020

Regional adiposity patterns in relation to lipids, lipoprotein cholesterol, and lipoprotein subfraction mass in men.

1 reference

12 December 2020

Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation.

1 reference

12 December 2020

The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus. A multicenter controlled clinical trial.

1 reference

12 December 2020

Severe drug-induced hypoglycemia: a review

1 reference

12 December 2020

Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study

1 reference

12 December 2020

Symptomatic hypoglycemia in NIDDM patients treated with oral hypoglycemic agents

1 reference

12 December 2020

Use of the short-acting insulin analogue lispro in intensive treatment of type 1 diabetes mellitus: importance of appropriate replacement of basal insulin and time-interval injection-meal

1 reference

12 December 2020

Sulphonylureas and hypoglycaemia

1 reference

12 December 2020

Sulfonylureas in NIDDM.

1 reference

12 December 2020

GLP-1 tablet in type 2 diabetes in fasting and postprandial conditions

1 reference

12 December 2020

Molecular physiology of amylin

1 reference

12 December 2020

Glibenclamide-associated hypoglycaemia: a report on 57 cases

1 reference

12 December 2020

Rationale for the use of insulin therapy alone as the pharmacological treatment of type 2 diabetes

1 reference

12 December 2020

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

The relationship between subsets of anthropometric upper versus lower body measurements and coronary heart disease risk in middle-aged men. The Paris Prospective Study. I

1 reference

12 December 2020

Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmö feasibility study

1 reference

12 December 2020

Improved postprandial glycemic control during treatment with Humalog Mix25, a novel protamine-based insulin lispro formulation. Humalog Mix25 Study Group.

1 reference

12 December 2020

Pas de deux or more: the sulfonylurea receptor and K+ channels

1 reference

12 December 2020

Oral antidiabetic agents. A guide to selection

1 reference

12 December 2020

Effect of metformin on carbohydrate and lipoprotein metabolism in NIDDM patients

1 reference

12 December 2020

Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment. Multicenter Insulin Lispro Study Group.

1 reference

12 December 2020

A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results

1 reference

12 December 2020

Effects of pramlintide, an analog of human amylin, on plasma glucose profiles in patients with IDDM: results of a multicenter trial

1 reference

12 December 2020

Pharmacological modification of digestion and absorption

1 reference

12 December 2020

Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone

1 reference

12 December 2020

Therapeutic approaches to type 2 diabetes. Proceedings of a conference. Scottsdale, Arizona, USA. 10-12 December 1997

1 reference

12 December 2020

Reduction of Postprandial Hyperglycemia in Subjects With IDDM by Intravenous Infusion of AC137, a Human Amylin Analogue

1 reference

12 December 2020

Pharmacology of alpha-glucosidase inhibition.

1 reference

12 December 2020

Clinical pharmacology of human insulin

1 reference

12 December 2020

Secondary failure to treatment with oral antidiabetic agents in non-insulin-dependent diabetes.

1 reference

12 December 2020

Enhancement of insulin sensitivity by troglitazone lowers blood pressure in diabetic hypertensives.

1 reference

12 December 2020

Mealtime treatment with insulin analog improves postprandial hyperglycemia and hypoglycemia in patients with non-insulin-dependent diabetes mellitus. Multicenter Insulin Lispro Study Group.

1 reference

12 December 2020

1 reference

12 December 2020

Structure and biology of amylin

1 reference

12 December 2020

Hyperinsulinemia as an independent risk factor for ischemic heart disease.

1 reference

12 December 2020

Incidence of severe sideeffects during therapy with sulfonylureas and biguanides.

1 reference

12 December 2020

[Lys(B28), Pro(B29)]-human insulin. A rapidly absorbed analogue of human insulin

1 reference

12 December 2020

Pramlintide, a synthetic analog of human amylin, improves the metabolic profile of patients with type 2 diabetes using insulin. The Pramlintide in Type 2 Diabetes Group

1 reference

12 December 2020

The impact of metformin therapy on hepatic glucose production and skeletal muscle glycogen synthase activity in overweight type II diabetic patients.

1 reference

12 December 2020

Different effects of glyburide and glipizide on insulin secretion and hepatic glucose production in normal and NIDDM subjects

1 reference

12 December 2020

Variability of the metabolic effect of soluble insulin and the rapid-acting insulin analog insulin aspart

1 reference

12 December 2020

1 reference

12 December 2020

Pharmacokinetics, pharmacodynamics and glucose counterregulation following subcutaneous injection of the monomeric insulin analogue [Lys(B28),Pro(B29)] in IDDM

1 reference

12 December 2020

Relationship of fat distribution to glucose tolerance. Results of computed tomography in male participants of the Normative Aging Study

1 reference

12 December 2020

Effects of caloric restriction and weight loss on glycemic control, insulin release and resistance, and atherosclerotic risk in obese patients with type II diabetes mellitus

1 reference

12 December 2020

Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients. Troglitazone Study Group.

1 reference

12 December 2020

Incidence of lactic acidosis in metformin users

1 reference

12 December 2020

Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.

1 reference

12 December 2020

Effect of acarbose on carbohydrate and lipid metabolism in NIDDM patients poorly controlled by sulfonylureas.

1 reference

12 December 2020

Drug therapy of non-insulin-dependent diabetes mellitus in the elderly

1 reference

12 December 2020

Sulphonylurea antidiabetic drugs. An update of their clinical pharmacology and rational therapeutic use.

1 reference

12 December 2020

Prandial glycaemia after a carbohydrate-rich meal in type I diabetic patients: using the rapid acting insulin analogue [Lys(B28), Pro(B29)] human insulin

1 reference

12 December 2020

A comparison of the effects of tolazamide and tolbutamide upon blood glucose and serum insulin and lipid levels in diabetic subjects

1 reference

12 December 2020

Gastric emptying, glucose responses, and insulin secretion after a liquid test meal: effects of exogenous glucagon-like peptide-1 (GLP-1)-(7-36) amide in type 2 (noninsulin-dependent) diabetic patients.

1 reference

12 December 2020

Insulin and atheroma. 20-yr perspective

1 reference

12 December 2020

Long-acting insulin analogs.

1 reference

12 December 2020

Effect of metformin on insulin-stimulated glucose turnover and insulin binding to receptors in type II diabetes

1 reference

12 December 2020

Current concepts in the pharmacological management of obesity

1 reference

12 December 2020

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

12 December 2020

Lilly Lecture: syndromes of insulin resistance. From patient to gene and back again

1 reference

12 December 2020

Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year

1 reference

12 December 2020

Long-term titrated-dose alpha-glucosidase inhibition in non-insulin-requiring Hispanic NIDDM patients

1 reference

12 December 2020

Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population.

1 reference

12 December 2020

Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

British Regional Heart Study: cardiovascular risk factors in middle-aged men in 24 towns

1 reference

12 December 2020

Troglitazone use in insulin-treated type 2 diabetic patients. The Troglitazone Insulin Study Group.

1 reference

12 December 2020

Effects of weight loss on mechanisms of hyperglycemia in obese non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Exogenous insulin administration and cardiovascular risk in non-insulin-dependent and insulin-dependent diabetes mellitus

1 reference

12 December 2020

Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.

1 reference

12 December 2020

Loss of abdominal fat and metabolic response to exercise training in obese women

1 reference

12 December 2020

Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus.

1 reference

12 December 2020

Multicenter, placebo-controlled trial comparing acarbose (BAY g 5421) with placebo, tolbutamide, and tolbutamide-plus-acarbose in non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

In vivo metformin treatment ameliorates insulin resistance: evidence for potentiation of insulin-induced translocation and increased functional activity of glucose transporters in obese (fa/fa) Zucker rat adipocytes

1 reference

12 December 2020

Improvement in glucose tolerance after 1 wk of exercise in patients with mild NIDDM.

1 reference

12 December 2020

Troglitazone: antihyperglycemic activity and potential role in the treatment of type 2 diabetes

1 reference

12 December 2020

Pramlintide: a human amylin analogue reduced postprandial plasma glucose, insulin, and C-peptide concentrations in patients with type 2 diabetes

1 reference

12 December 2020

A summary of criticisms of the findings and conclusions of the University Group Diabetes Program (UGDP)

1 reference

12 December 2020

Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjects

1 reference

12 December 2020

Risk factors for ischaemic heart disease: is it time to measure insulin?

1 reference

12 December 2020

Troglitazone: a review of its use in the management of type 2 diabetes mellitus

1 reference

12 December 2020

Causes of weight gain during insulin therapy with and without metformin in patients with Type II diabetes mellitus

1 reference

12 December 2020

Diarrhea and Metformin in a Diabetic Clinic

1 reference

12 December 2020

Effect of metformin treatment on insulin action in diabetic rats: in vivo and in vitro correlations.

1 reference

12 December 2020

Improved glycemic control with insulin aspart: a multicenter randomized double-blind crossover trial in type 1 diabetic patients. UK Insulin Aspart Study Group.

1 reference

12 December 2020

Glimepiride, a new once-daily sulfonylurea. A double-blind placebo-controlled study of NIDDM patients. Glimepiride Study Group.

1 reference

12 December 2020

A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44)

1 reference

12 December 2020

Pharmacologic therapy for type 2 diabetes mellitus

1 reference

12 December 2020

Drug treatment of non-insulin-dependent diabetes mellitus in the 1990s. Achievements and future developments

1 reference

12 December 2020

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

1 reference

12 December 2020

Pre-meal insulin analogue insulin lispro vs Humulin R insulin treatment in young subjects with type 1 diabetes.

1 reference

12 December 2020

Methods for voluntary weight loss and control. NIH Technology Assessment Conference Panel. Consensus Development Conference, 30 March to 1 April 1992

1 reference

12 December 2020

Exercise and physical training: effects on insulin sensitivity and glucose metabolism

1 reference

12 December 2020

The effect of acarbose and miglitol (BAY-M-1099) on postprandial glucose levels following ingestion of various sources of starch by nondiabetic and streptozotocin-induced diabetic rats

1 reference

12 December 2020

Metabolic effects of metformin in non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Controversy Over Study of Diabetes Drugs Continues for Nearly a Decade

1 reference

12 December 2020

Therapeutic potentials of acarbose as first-line drug in NIDDM insufficiently treated with diet alone

1 reference

12 December 2020

The association of girth measurements with disease in 32,856 women

1 reference

12 December 2020

Amylin concentrations and glucose control

1 reference

12 December 2020

Injection site effects on the pharmacokinetics and glucodynamics of insulin lispro and regular insulin

1 reference

12 December 2020

1 reference

12 December 2020

A study of the effects of hypoglycemia agents on vascular complications in patients with adult-onset diabetes. VI. Supplementary report on nonfatal events in patients treated with tolbutamide

1 reference

12 December 2020

Pharmacokinetics and metabolic effects of glibenclamide and glipizide in type 2 diabetics.

1 reference

12 December 2020

Effects of the carbohydrase inhibitor miglitol in sulfonylurea-treated NIDDM patients

1 reference

12 December 2020

Cellular mechanism of action of metformin

1 reference

12 December 2020

Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VII. Mortality and selected nonfatal events with insulin treatment

1 reference

12 December 2020

Overview of current therapeutic options in type 2 diabetes. Rationale for combining oral agents with insulin therapy

1 reference

12 December 2020

Effects of troglitazone: a new hypoglycemic agent in patients with NIDDM poorly controlled by diet therapy.

1 reference

12 December 2020

Human insulin analogue [LYS(B28), PRO(B29)]: the ideal pump insulin?

1 reference

12 December 2020

Drug therapy of postprandial hyperglycaemia.

1 reference

12 December 2020

Impaired glucose tolerance is normalized by treatment with the thiazolidinedione troglitazone.

1 reference

12 December 2020

10.2165/00003495-200060010-00006

Identifiers

DOI

1 reference

PubMed ID

10929931

Dimensions Publication ID

30 July 2017

0 references

1 reference

PubMed ID

10929931